Skip to results
Modify your search
NARROW
1-18 of 18
Authors: Patricia O'Hare
Journal Article
ATRT-04. RETROSPECTIVE ANALYSIS OF 271 RELAPSED AND REFRACTORY ATYPICAL TERATOID RHABDOID TUMORS – COMBING DATA FROM INTERNATIONAL COHORTS IN A COLLABORATIVE EFFORT Open Access
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.004
Published: 18 June 2024
Journal Article
EPEN-03. THE MANAGEMENT OF PEDIATRIC AND ADOLESCENT SPINAL EPENDYMOMA; A 20-YEAR NATIONAL EVALUATION INVOLVING UNITED KINGDOM PEDIATRIC ONCOLOGY PRIMARY TREATMENT CENTERS ON BEHALF OF THE UK CHILDREN’S CANCER AND LEUKAEMIA GROUP (CCLG) Open Access
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.205
Published: 18 June 2024
Journal Article
QOL-15. PAEDIATRIC LOW-GRADE GLIOMA (PLGG): A LIFELONG DISEASE THAT BEGINS IN CHILDHOOD. EVALUATION AND PROGNOSTICATION OF LONG-TERM PLGG SURVIVOR FUNCTIONAL AND QUALITY OF LIFE OUTCOMES Open Access
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.603
Published: 18 June 2024
Journal Article
LGG-18. BEVACIZUMAB: GOOD FOR EYES AND MRI’S! A NATIONAL UK ASSESSMENT OF VISUAL AND RADIOLOGICAL OUTCOMES OF BEVACIZUMAB THERAPY IN PAEDIATRIC LOW-GRADE GLIOMA (PLGG) Open Access
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.411
Published: 18 June 2024
Journal Article
EDITOR'S CHOICE
Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions—International Pediatric Low-Grade Glioma Coalition Open Access
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1357–1366, https://doi.org/10.1093/neuonc/noae074
Published: 14 May 2024
Journal Article
A nationwide evaluation of bevacizumab-based treatments in pediatric low-grade glioma in the UK: Safety, efficacy, visual morbidity, and outcomes Open Access
Neuro-Oncology, Volume 25, Issue 4, April 2023, Pages 774–785, https://doi.org/10.1093/neuonc/noac223
Published: 14 October 2022
Journal Article
LGG-09. A Nationwide Service Evaluation of Safety, Radiologic and Visual Outcome Refining Bevacizumab-based Treatments in Children with Progressive Low-Grade Glioma Open Access
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i89, https://doi.org/10.1093/neuonc/noac079.325
Published: 03 June 2022
Journal Article
LGG-37. Long-term Outcome, Visual Morbidity and Prognostic Factors in Infants and Young Children with Optic Pathway Glioma from the Great Ormond Street Hospital (GOSH) LGG - Cohort Open Access
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i96, https://doi.org/10.1093/neuonc/noac079.349
Published: 03 June 2022
Journal Article
LGG-33. A 40-year cohort study of evolving hypothalamic dysfunction in 90 infants and young children (<3y) with optic pathway gliomas Open Access
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i95, https://doi.org/10.1093/neuonc/noac079.345
Published: 03 June 2022
Journal Article
LGG-46. Survival Of The Fittest? A Prognostic Evaluation of Paediatric Low-Grade Glioma (PLGG) Survivor Functional Outcomes Open Access
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Pages i98–i99, https://doi.org/10.1093/neuonc/noac079.358
Published: 03 June 2022
Journal Article
ATRT-20. Novel prognostic molecular signatures for improved risk-classification of Atypical Teratoid Rhabdoid Tumours Open Access
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i7, https://doi.org/10.1093/neuonc/noac079.019
Published: 03 June 2022
Journal Article
MODL-19. DIPG HARBOUR ALTERATIONS TARGETABLE BY MEK INHIBITORS, WITH ACQUIRED RESISTANCE MECHANISMS OVERCOME BY COMBINATORIAL UP- OR DOWN-STREAM INHIBITION Open Access
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii414, https://doi.org/10.1093/neuonc/noaa222.592
Published: 04 December 2020
Journal Article
DDRE-07. DIPG HARBOUR ALTERATIONS TARGETABLE BY MEK INHIBITORS, WITH ACQUIRED RESISTANCE MECHANISMS OVERCOME BY COMBINATORIAL INHIBITION Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii62, https://doi.org/10.1093/neuonc/noaa215.252
Published: 09 November 2020
Journal Article
DIPG-25. GENETIC ALTERATIONS TARGETING THE MAPK PATHWAY CONFERS PRECLINICAL SENSITIVITY TO TRAMETINIB IN A CO-CLINICAL TRIAL IN DIPG Free
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii74, https://doi.org/10.1093/neuonc/noz036.046
Published: 23 April 2019
Journal Article
ATRT-23. SMARCB1-DEPENDENCIES IN ATYPICAL TERATOID/RHABDOID TUMOURS: A STRATEGY FOR PRE-CLINICAL THERAPEUTIC TARGET IDENTIFICATION IN THE ABSENCE OF ACTIONABLE MUTATIONS Free
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Pages i32–i33, https://doi.org/10.1093/neuonc/noy059.021
Published: 22 June 2018
Journal Article
ATRT-20. INTRA- AND EXTRA-CRANIAL MALIGNANT RHABDOID TUMOURS SHARE COMMON LOCATION-INDEPENDENT CLINICAL AND MOLECULAR DISEASE CHARACTERISTICS Free
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Pages i31–i32, https://doi.org/10.1093/neuonc/noy059.018
Published: 22 June 2018
Journal Article
ATRT-29. SUCCESS OF HIGH DOSE CHEMOTHERAPY IN INFANTS PRESENTING WITH ATYPICAL TERATOID RHABDOID TUMOURS (ATRT) Free
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i34, https://doi.org/10.1093/neuonc/noy059.027
Published: 22 June 2018
Journal Article
LGG-43. CLINICAL EXPERIENCE OF BRAF AND MEK INHIBITOR THERAPY IN PAEDIATRIC GLIOMA Free
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Pages i113–i114, https://doi.org/10.1093/neuonc/noy059.384
Published: 22 June 2018
